DiscoverThe Intellectual People PodcastTreat Early - Fluvoxamine, Camostat, Selva SLV213, Doxazosin and Niclosamide | Steve Kirsch | Ep 39
Treat Early - Fluvoxamine, Camostat, Selva SLV213, Doxazosin and Niclosamide | Steve Kirsch | Ep 39

Treat Early - Fluvoxamine, Camostat, Selva SLV213, Doxazosin and Niclosamide | Steve Kirsch | Ep 39

Update: 2021-09-16
Share

Description

Entrepreneur Steve Kirsch who holds an early patent for the optical mouse decided to get involved in treating Covid.  Steve put in $1MM of his own money and  raised $5MM in an effort to treat Covid in the early stage.




https://www.treatearly.org 


https://en.wikipedia.org/wiki/Steve_K... 


#treatearly 


#covid 


#fluvoxamine

Comments 
loading
In Channel
Geshelli Labs | Ep 40

Geshelli Labs | Ep 40

2021-09-3040:30

loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Treat Early - Fluvoxamine, Camostat, Selva SLV213, Doxazosin and Niclosamide | Steve Kirsch | Ep 39

Treat Early - Fluvoxamine, Camostat, Selva SLV213, Doxazosin and Niclosamide | Steve Kirsch | Ep 39

Jason